SpaceX Earnings Report… And What’s Next for the Pharma Trade 8/4/26
SpaceX on the move in after-hours trading on the back of its first earnings report since going public. Can investors expect SpaceX to blast off, or will the aerospace giant sink even further below its IPO price?Then, major Pharma earnings from giants like Pfizer and Merck beating Wall Street estimates with Amgen and…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from CNBC's "Fast Money"
See all episodes →Market Resilience Despite Surge In Yields… And Options Action Ahead Of Micron Results 9/25/26
Meta’s Rally Keeps Rocking… And A Major AI Safety Warning 9/24/26
U.S. 10-Year Yield Hits 19-Year High… And The Ripple Effects From Meta’s Muse 9/23/26
Similar episodes from other shows
More like CNBC's "Fast Money" →
Tesla Accelerates
CNBC Fast Money Special Edition 7/12/22
Turbulente SpaceX-Premiere und der KI-Assistent fürs Depot
67%The 3 ETFs That Let You Buy The Next SpaceX Before It Goes Public (BUY TODAY)
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.